{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:46:00Z","timestamp":1793065560174,"version":"4.5.0"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003872","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T21:54:29Z","timestamp":1389304469000},"page":"e1003872","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":107,"title":["Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART"],"prefix":"10.1371","volume":"10","author":[{"given":"Paul W.","family":"Denton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Wietgrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Sykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Ann","family":"Spagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Perkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancie M.","family":"Archin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh K.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Hudgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley T.","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Victor","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","article-title":"Life expectancy living with HIV: recent estimates and future implications","volume":"26","author":"F Nakagawa","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"DD Richman","year":"2009","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3262","article-title":"Towards an HIV cure: a global scientific strategy","volume":"12","author":"SG Deeks","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.it.2012.07.001","article-title":"Developing strategies for HIV-1 eradication","volume":"33","author":"CM Durand","year":"2012","journal-title":"Trends Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: Shock and kill","volume":"487","author":"SG Deeks","year":"2012","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2012.01.014","article-title":"Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation","volume":"36","author":"L Shan","year":"2012","journal-title":"Immunity"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1570162043484915","article-title":"Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it","volume":"2","author":"DH Hamer","year":"2004","journal-title":"Curr HIV Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1000803","DOI":"10.1371\/journal.ppat.1000803","article-title":"Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs","volume":"6","author":"EA Berger","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.immunol.14.1.49","article-title":"Immunotoxins: an update","volume":"14","author":"GR Thrush","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(96)00995-3","article-title":"Therapeutic potential of anti-HIV immunotoxins","volume":"33","author":"SH Pincus","year":"1996","journal-title":"Antiviral Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/10611869808995861","article-title":"Rationale for the use of immunotoxins in the treatment of HIV-infected humans","volume":"5","author":"MG Van Oijen","year":"1998","journal-title":"J Drug Target"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14712598.3.5.843","article-title":"Anthrax toxin: structures, functions and tumour targeting","volume":"3","author":"S Liu","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"ref13","first-page":"13","article-title":"The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma","volume":"234","author":"A Engert","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1073\/pnas.86.6.1987","article-title":"Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain","volume":"86","author":"MA Till","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.4049\/jimmunol.142.9.3070","article-title":"Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates","volume":"142","author":"SH Pincus","year":"1989","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.2847316","article-title":"HIV-infected cells are killed by rCD4-ricin A chain","volume":"242","author":"MA Till","year":"1988","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/335369a0","article-title":"Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein","volume":"335","author":"VK Chaudhary","year":"1988","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"9539","DOI":"10.1073\/pnas.86.23.9539","article-title":"CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses","volume":"86","author":"EA Berger","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1073\/pnas.90.4.1411","article-title":"Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus","volume":"90","author":"KD Bell","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.96.20.11482","article-title":"An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro","volume":"96","author":"C McCoig","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1073\/pnas.90.1.332","article-title":"Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus","volume":"90","author":"SH Pincus","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03401745","article-title":"Specific killing of HIV-infected lymphocytes by a recombinant immunotoxin directed against the HIV-1 envelope glycoprotein","volume":"4","author":"TK Bera","year":"1998","journal-title":"Mol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/COH.0b013e32835fc68a","article-title":"Overcoming pharmacologic sanctuaries","volume":"8","author":"TJ Cory","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","article-title":"Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1","volume":"12","author":"MW Melkus","year":"2006","journal-title":"Nat Med"},{"key":"ref25","first-page":"135","article-title":"Humanized mouse models of HIV infection","volume":"13","author":"PW Denton","year":"2011","journal-title":"AIDS Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.tim.2012.03.007","article-title":"Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice","volume":"20","author":"PW Denton","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2012.31","article-title":"IL-2 receptor gamma-chain molecule is critical for intestinal T-cell reconstitution in humanized mice","volume":"5","author":"PW Denton","year":"2012","journal-title":"Mucosal Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1128\/JVI.06676-11","article-title":"Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice","volume":"86","author":"BR Long","year":"2012","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1128\/JVI.02207-08","article-title":"Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice","volume":"83","author":"DM Brainard","year":"2009","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-4690-9-44","article-title":"Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes","volume":"9","author":"W Zou","year":"2012","journal-title":"Retrovirology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.20062411","article-title":"Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1","volume":"204","author":"Z Sun","year":"2007","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pmed.0050016","article-title":"Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice","volume":"5","author":"PW Denton","year":"2008","journal-title":"PLoS Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2649","article-title":"A quantitative basis for antiretroviral therapy for HIV-1 infection","volume":"18","author":"BL Jilek","year":"2012","journal-title":"Nat Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/QAI.0b013e31828ace69","article-title":"Durable Efficacy and Safety of Raltegravir versus Efavirenz When Combined With Tenofovir\/Emtricitabine In Treatment-Naive HIV-1 Infected Patients: Final Five-Year Results From STARTMRK","volume":"63","author":"JK Rockstroh","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.06120-11","article-title":"Generation of HIV latency in BLT humanized mice","volume":"86","author":"PW Denton","year":"2012","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.0800050105","article-title":"Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy","volume":"105","author":"S Palmer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"B Autran","year":"1997","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0b013e328350fb3c","article-title":"Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards","volume":"26","author":"JM Murray","year":"2012","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/AAC.42.3.612","article-title":"Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA","volume":"42","author":"BL Robbins","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/AAC.36.11.2423","article-title":"Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine","volume":"36","author":"RF Schinazi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.antiviral.2011.08.008","article-title":"Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes","volume":"92","author":"F Scopelliti","year":"2011","journal-title":"Antiviral Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/00002030-200110190-00008","article-title":"Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despite effective HAART","volume":"15","author":"A Lafeuillade","year":"2001","journal-title":"AIDS"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1189\/jlb.0306139","article-title":"Anti-HIV-1 immunotoxin 3B3(Fv)-PE38: enhanced potency against clinical isolates in human PBMCs and macrophages, and negligible hepatotoxicity in macaques","volume":"80","author":"PE Kennedy","year":"2006","journal-title":"J Leukoc Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/315351","article-title":"Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy\/liv-SCID-Hu mice","volume":"181","author":"H Goldstein","year":"2000","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1086\/317615","article-title":"Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection","volume":"182","author":"JN Blankson","year":"2000","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1073\/pnas.0711372105","article-title":"Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle","volume":"105","author":"AR Sedaghat","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1315295110","article-title":"HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice","volume":"110","author":"JA Horwitz","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1073\/pnas.91.9.3809","article-title":"In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity","volume":"91","author":"CF Barbas 3rd","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1128\/JVI.02356-09","article-title":"Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS","volume":"84","author":"TW North","year":"2010","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/jit308","article-title":"The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence","volume":"208","author":"SA Yukl","year":"2013","journal-title":"J Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1358\/dof.2010.035.010.1534010","article-title":"Cytotoxic therapy with diphtheria toxin fusion proteins","volume":"35","author":"JH Woo","year":"2010","journal-title":"Drugs of the Future"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1111\/j.1742-4658.2011.08182.x","article-title":"A guide to taming a toxin\u2013recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer","volume":"278","author":"JE Weldon","year":"2011","journal-title":"FEBS J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JVI.69.1.75-81.1995","article-title":"Unique insertion sequence and pattern of CD4 expression in variants selected with immunotoxins from human immunodeficiency virus type 1-infected T cells","volume":"69","author":"H Fang","year":"1995","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/COH.0b013e3283412515","article-title":"Targeted cytotoxic therapy: adapting a rapidly progressing anticancer paradigm for depletion of persistent HIV-infected cell reservoirs","volume":"6","author":"EA Berger","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/COH.0b013e32835ef0a1","article-title":"Curing HIV: lessons from cancer therapy","volume":"8","author":"R Mitsuyasu","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1128\/JVI.00537-11","article-title":"One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates","volume":"85","author":"PW Denton","year":"2011","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e1002732","DOI":"10.1371\/journal.ppat.1002732","article-title":"Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice","volume":"8","author":"A Wahl","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e1003242","DOI":"10.1371\/journal.ppat.1003242","article-title":"HIV Restriction by APOBEC3 in Humanized Mice","volume":"9","author":"JF Krisko","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.274.5289.985","article-title":"Quantitative image analysis of HIV-1 infection in lymphoid tissue","volume":"274","author":"AT Haase","year":"1996","journal-title":"Science"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003872","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T18:18:38Z","timestamp":1688926718000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003872"}},"subtitle":[],"editor":[{"given":"Daniel C.","family":"Douek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003872","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}